Alphatec Holdings CEO Miles Patrick sold 100,000 shares worth $2.1 million in a prearranged transaction, reducing his direct holdings by 6.82%. Despite the insider sale, the article maintains a bullish outlook, noting the company's strong operational momentum with 30% YoY revenue growth, expanding margins, and raised full-year guidance. The CEO retains over 5.1 million shares, maintaining alignment with shareholders.

Alphatec Holdings COO Scott Lish sold 19,900 shares worth approximately $390,836 on December 16, 2025. Despite the insider sale, the article suggests this is not a red flag as Lish retained over 640,000 shares. The sale occurred during a strong price run-up (127% annual return), with the stock's P/S ratio doubling to over 4x. While the company shows solid fundamentals with 30% YoY revenue growth and improving margins, the analyst recommends waiting for a price pullback before buying.

Alphatec Holdings' HR executive Craig Hunsaker sold 100,000 shares worth $2 million, representing 7.2% of his stake. The company has seen strong quarterly performance with 30% revenue growth and is approaching positive free cash flow in 2025.

Alphatec Holdings (NASDAQ:ATEC) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 4 0 0 0 0 3M Ago 2 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Alphatec Holdings, presenting an average target of $21.57, a high estimate of $25.00, and a low estimate of $19.00. Witnessing a positive shift, the current average has risen by 5.22% from the previous average price target of $20.50. Exploring Analyst Ratings: An In-Depth Overview An in-depth analysis of recent analyst actions unveils how financial experts perceive Alphatec Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target David Saxon Needham Maintains Buy $23.00 - David Saxon Needham Raises Buy $23.00 $22.00 Caitlin Cronin Canaccord Genuity Maintains Buy $25.00 - David Saxon Needham Raises Buy $22.00 $19.00 David Saxon Needham Maintains Buy $19.00 - Sean Lee HC Wainwright & Co. Maintains Buy $20.00 - David Saxon Needham Maintains Buy $19.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments ...Full story available on Benzinga.com

OrthoPediatrics (KIDS) delivered earnings and revenue surprises of 28.57% and 7.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

4 analysts have shared their evaluations of Alphatec Holdings (NASDAQ:ATEC) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $19.0, a high estimate of $20.00, and a low estimate of $18.00. Witnessing a positive shift, the current average has risen by 18.75% from the previous average price target of $16.00. Diving into Analyst Ratings: An In-Depth Exploration The standing of Alphatec Holdings among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target David Saxon Needham Maintains Buy $19.00 - Sean Lee HC Wainwright & Co. Maintains Buy $20.00 - David Saxon Needham Maintains Buy $19.00 - David Saxon Needham Raises Buy $18.00 $16.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments ...Full story available on Benzinga.com

Analysts' ratings for Alphatec Holdings (NASDAQ:ATEC) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $19.0, along with a high estimate of $20.00 and a low estimate of $18.00. This upward trend is evident, with the current average reflecting a 18.75% increase from the previous average price target of $16.00. Investigating Analyst Ratings: An Elaborate Study In examining recent analyst actions, we gain insights into how financial experts perceive Alphatec Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target David Saxon Needham Maintains Buy $19.00 - Sean Lee HC Wainwright & Co. Maintains Buy $20.00 - David Saxon Needham Maintains Buy $19.00 - David Saxon Needham Raises Buy $18.00 $16.00 Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related ...Full story available on Benzinga.com

Alphatec (ATEC) delivered earnings and revenue surprises of -32.14% and 0.27%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Alphatec Holdings (NASDAQ:ATEC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 0 0 0 Last 30D 0 1 0 0 0 1M Ago 3 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, Alphatec Holdings has an average price target of $19.75 with a high of $24.00 and a low of $16.00. Below is a summary of how these 4 ...Full story available on Benzinga.com

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Piper Sandler increased Alteryx, Inc. (NYSE: AYX) price target from $30 to $32. Piper Sandler analyst Brent Bracelin maintained an Underweight rating. Alteryx shares gained 17% to $35.50 in pre-market trading. See how other analysts view this stock. Keybanc cut the price target for IAC Inc. (NASDAQ: IAC) from $81 to $72. Keybanc analyst Justin Patterson maintained an Overweight rating. IAC shares fell 1.1% to close at $44.29 on Monday. See how other analysts view this stock. DA Davidson raised Appian Corporation (NASDAQ: APPN) price target from $50 to $55. DA Davidson analyst Gil Luria upgraded the stock from Neutral to Buy. Appian shares fell 6.3% to close at $37.40 ...Full story available on Benzinga.com

The spine surgery solutions company fell after pricing a $150 million public offering of common stock. Here's what investors need to know.

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. Nuvve Holding Corp. (NASDAQ: NVVE) shares climbed 88% to $0.2789 after falling 10% on Tuesday. Nuvve recently announced pricing of a $1 million underwritten public offering of roughly 7 million shares of common stock at a price to the public of $0.14 per share. BIO-key International, Inc. (NASDAQ: BKYI) surged 57% to $0.30. BIO-key International reported results for its third quarter ended Sept. 30, 2023. ReShape Lifesciences Inc. (NASDAQ: RSLS) gained 44.7% to $0.2976 after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million public offering. BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares climbed 37.6% to $3.2199 after announcing positive findings from an independent third party audit of the data integrity at TRANQUILITY II Phase 3 trial site. ParaZero Technologies Ltd. (NASDAQ: PRZO) gained 26% to $2.0350. Catalyst Biosciences, Inc. (NASDAQ: CBIO) climbed 18% to $0.5095. Scholar Rock Holding Corporation (NASDAQ: SRRK) gained 16.5% to $8.92. Jefferies upgraded Scholar Rock from Hold to Buy and announced a $20 price target. Stride, Inc. (NYSE: LRN) rose 16.4% to $51.81 after the company reported first-quarter results. OncoCyte Corporation (NASDAQ: OCX) gained 14.4% to $2.86. Urgent.ly Inc. (NASDAQ: ULY) surged 14% to $5.01. GameSquare Holdings, Inc. (NASDAQ: GAME) gained 13.1% to $2.07. Treasure Global Inc. (NASDAQ: TGL) rose 12.8% to $0.4501. PROG Holdings, Inc. (NYSE: PRG) rose 9.3% to $31.14 following upbeat quarterly results. LumiraDx Limited (NASDAQ: LMDX) gained 8.4% to $0.1680 after dipping around 44% on Tuesday. John Bean Technologies Corporation (NYSE: JBT) surged 8.1% to $104.00 after posting strong quarterly earnings. Sonendo, Inc. (NYSE: SONX) shares gained 8% to $0.2483 after falling over 23% on Tuesday. Sonendo recently announced preliminary revenue results for the third quarter. Crown ElectroKinetics Corp. (NASDAQ: CRKN) climbed 8% to $0.2700. Deutsche Bank Aktiengesellschaft (NYSE: DB) rose 6.6% to $10.72 after the company reported a year-over-year increase in third-quarter EPS and sales results. Deutsche Bank Aktiengesellschaft (NYSE: DB) gained 6.6% to $10.72 after the company reported a year-over-year increase in third-quarter EPS and sales results. The Gap, Inc. (NYSE: GPS) climbed 6.2% ...